Expert advisers will consider today how two companies assessed potential risks with their proposed first-ever gene-editing treatment for sickle cell disease, a rare condition that disproportionately affects people of color.
Jim Jones, the FDA's newly designated deputy commissioner of human foods, sees partnering with food industry stakeholders as crucial to accomplishing the food safety goals of the agency.
The agency’s Center for Tobacco Products is hosting a two-day public meeting through today on best practices when asking the regulator to authorize new tobacco products — including e-cigarettes.
